Delivery Order W81XWH15D0037-W81XWH18F0066
Award Date
3/20/18
Potential Completion Date
8/16/19
Potential Value
$588K
Federal Agency
Medical Command
Awardee
Dynport Vaccine Company LLC
Ultimate Awardee
General Dynamics Corp
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Detrick, MD 21702, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,159,290,240.64 cost-plus-award-fee contract awarded by the Department of the Army Medical Command to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The contract, which has no set-aside designation, is for research, development, manufacturing, and testing services to support biopharmaceutical products targeting infectious diseases. Dynport has provided similar services under past federal contracts with NIH, HHS, and the Joint Program Executive Office for...
This is a cost-plus-fixed-fee delivery order awarded by the Medical Command (MEDCOM) of the U.S. Army to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation. The $1,685,156.08 contract is for the Phase 2 clinical trial of the Comprehensive Preventive and Preparedness (CPP) program, which develops medical countermeasures for infectious diseases. The contract is part of Dynport's existing $30 million Preclinical Services for Biopharmaceutical Product Development indefinite...
This is a $28,836,234.91 firm fixed price contract awarded by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The contract is for stability testing of critical material lots for the rBV A/B and rF1V vaccine programs, which are in advanced development to protect against botulism and pneumonic plague. The contract has a completion date of December 15, 2027. Dynport Vaccine Company...
This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Health Agency (DHA) to General Dynamics Information Technology, Inc. (GDIT) on February 23, 2021, with a total potential value of $124,990.66 and a period of performance ending on February 22, 2022. The contract is part of the Duchenne Muscular Dystrophy Research Program (DMDRP) under the Congressionally Directed Medical Research Programs (CDMRP) and the Combat Casualty Care Research Program (CCCRP) of the Joint Program...
This federal contract award was issued by the Defense Health Agency (DHA) to General Dynamics Information Technology, Inc. (GDIT), a subsidiary of General Dynamics Corporation. The $176,997.01 Delivery Order contract is for the Fiscal Year 2024 Bone Marrow Failure Research Program. The contract does not have a set-aside designation. The award supports advanced medical research and technological solutions that directly benefit military personnel's health and operational effectiveness. GDIT has...
This is a $81,383,831.70 Delivery Order contract awarded by the Defense Health Agency (DHA) to General Dynamics Information Technology, Inc. (GDIT) under the General Services Administration's Professional Services Schedule (PSS). The contract provides ongoing support services for the U.S. Army Medical Materiel Development Activity (USAMMDA) at Fort Detrick, Maryland, and does not have a set-aside designation. GDIT has subcontracted portions of the work to small businesses including Rolaja LLC,...
This federal contract award, valued at $425,889.38, was issued by the Defense Health Agency (DHA) to General Dynamics Information Technology, Inc. (GDIT), a subsidiary of General Dynamics Corporation. The contract is for Reconstructive Transplant Research Program Support Services in support of the Congressionally Directed Medical Research Programs. This is a delivery order contract with a cost-plus-fixed-fee pricing type. The contract has an ultimate completion date of August 28, 2024. GDIT...
This is a $200,891.21 delivery order contract awarded by the U.S. Army Medical Command (MEDCOM) to General Dynamics Information Technology, Inc. (GDIT), a subsidiary of General Dynamics Corporation. The contract is for information technology services and solutions in support of the Congressionally Directed Medical Research Programs (CRMRP) and the Joint Program Committee 8 (JPC-8) Research, Test, and Evaluation (RTR) efforts. The contract is a time and materials type, with a period of...
This is a delivery order contract awarded by the Defense Health Agency to General Dynamics Information Technology, Inc. (GDIT), a subsidiary of General Dynamics Corporation. The contract, valued at $93,197.68, is for fiscal year 2018 and has a July 2019 completion date. The contract type is cost plus fixed fee, and there is no set-aside designation. GDIT, as the prime contractor, will be performing the work at Fort Detrick, Maryland. The contract is for services related to the Tissue Injury...
This is a federal contract award to General Dynamics Information Technology, Inc. (GDIT), a division of CSRA LLC, by the U.S. Army Medical Command (MEDCOM). The contract is a Delivery Order under the FY16 Joint Program Committee-2/Military Infectious Diseases Research Program (JPC-2/MIDRP) with a ceiling value of $198,103.00 and a performance period ending on January 28, 2017. The contract is for time and materials services and does not have a set-aside designation. As a major information...